IMVT icon

Immunovant

Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$33
27% upside
High target

3 analyst ratings

positive
neutral
67%
negative
Analyst & Firm Rating Price Target Upside
Downside
Date
Truist Securities
Truist Securities
Danielle Brill
8 Jan ‘26 10 days ago
Wolfe Research
Wolfe Research
Andy Chen
100% 1-yr IMVT win rate
6 Jan ‘26 12 days ago
Goldman Sachs
Goldman Sachs
Corinne Johnson
15 Dec ‘25 1 month ago